NO-releasing agents, such as JS-K ( O 2 -(2,4-dinitrophenyl)-1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate) 123 and PABA/NO ( O 2 -[2,4-dinitro-5-( N -methyl- N -4 carboxyphenylamino)phenyl] 1- N , N -dimethylamino)diazen-1-ium-1,2-diolate) 124 , are able to induce differentiation and cell death in a variety of cancer cells through GSH consumption, DNA synthesis inhibition and inhibition of enzymes involved in the defense against cell damage
Where is the peptide sourced, and is it from a licensed US compounding pharmacy
Yang WS, SriRamaratnam R, Welsch ME, et al
If you experience any severe or persistent side effects, you should contact your healthcare provider immediately
This combination is investigated in experimental models for its effects on visceral fat reduction , lean mass support , and IGF-1 modulation through complementary pituitary pathways